These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Successful revascularization of acute carotid stent thrombosis by facilitated thrombolysis. Steiner-Böker S; Cejna M; Nasel C; Minar E; Kopp CW AJNR Am J Neuroradiol; 2004 Sep; 25(8):1411-3. PubMed ID: 15466343 [TBL] [Abstract][Full Text] [Related]
25. [Reteplase. A new thrombolytic agent in the treatment of acute myocardial infarction]. Jurlander B; Grande P Ugeskr Laeger; 1998 Jun; 160(24):3577-80. PubMed ID: 9641050 [No Abstract] [Full Text] [Related]
26. Time to treatment and cost of thrombolysis: a multicenter comparison of tPA and rPA. Seyedroudbari A; Kessler ER; Mooss AN; Wundeman RL; Bala M; Hilleman DE J Thromb Thrombolysis; 2000 Apr; 9(3):303-8. PubMed ID: 10728031 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: one-year follow-up results of the Assessment of the Safety of a New Thrombolytic-3 (ASSENT-3) randomized trial in acute myocardial infarction. Sinnaeve PR; Alexander JH; Bogaerts K; Belmans A; Wallentin L; Armstrong P; Adgey JA; Tendera M; Diaz R; Soares-Piegas L; Vahanian A; Granger CB; Van De Werf FJ Am Heart J; 2004 Jun; 147(6):993-8. PubMed ID: 15199346 [TBL] [Abstract][Full Text] [Related]
28. Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial. Kastrati A; Mehilli J; Schlotterbeck K; Dotzer F; Dirschinger J; Schmitt C; Nekolla SG; Seyfarth M; Martinoff S; Markwardt C; Clermont G; Gerbig HW; Leiss J; Schwaiger M; Schömig A; JAMA; 2004 Feb; 291(8):947-54. PubMed ID: 14982910 [TBL] [Abstract][Full Text] [Related]
29. Facilitated PCI in patients with ST-elevation myocardial infarction. Ellis SG; Tendera M; de Belder MA; van Boven AJ; Widimsky P; Janssens L; Andersen HR; Betriu A; Savonitto S; Adamus J; Peruga JZ; Kosmider M; Katz O; Neunteufl T; Jorgova J; Dorobantu M; Grinfeld L; Armstrong P; Brodie BR; Herrmann HC; Montalescot G; Neumann FJ; Effron MB; Barnathan ES; Topol EJ; N Engl J Med; 2008 May; 358(21):2205-17. PubMed ID: 18499565 [TBL] [Abstract][Full Text] [Related]
30. ST-segment resolution 60 minutes after combination treatment of abciximab with reteplase or reteplase alone for acute myocardial infarction (30-day mortality results from the resolution of ST-segment after reperfusion therapy substudy). Cura FA; Roffi M; Pasca N; Wolski KE; Lincoff AM; Topol EJ; Lauer MS; Am J Cardiol; 2004 Oct; 94(7):859-63. PubMed ID: 15464665 [TBL] [Abstract][Full Text] [Related]
31. Clinical and economic lessons from studies of coronary thrombolysis. Mark DB J Vasc Interv Radiol; 1995; 6(6 Pt 2 Suppl):94S-101S. PubMed ID: 8770850 [TBL] [Abstract][Full Text] [Related]
32. Reteplase (Retavase). Med Lett Drugs Ther; 1997 Feb; 39(995):17-8. PubMed ID: 9057777 [No Abstract] [Full Text] [Related]
33. Coupling drug and catheter therapy for myocardial infarction. Lincoff AM JAMA; 2004 Feb; 291(8):1000-2. PubMed ID: 14982917 [No Abstract] [Full Text] [Related]
36. [Thrombolytic agents, urokinase, tissue-type plasminogen activator and pro-urokinase--their routes of administration and dosage: comparison between intracoronary thrombolysis and intravenous coronary thrombolysis]. Motomiya T Nihon Rinsho; 2003 Apr; 61 Suppl 4():441-5. PubMed ID: 12735012 [No Abstract] [Full Text] [Related]
37. Comparison of errors in estimating weight and in dosing of single-bolus tenecteplase with tissue plasminogen activator (TIMI 10B and ASSENT I). Murphy SA; Gibson CM; Van de Werf F; McCabe CH; Cannon CP Am J Cardiol; 2002 Jul; 90(1):51-4. PubMed ID: 12088781 [No Abstract] [Full Text] [Related]
38. [Increased efficacy of thrombolytic therapy in acute myocardial infarction by improved properties of new thrombolytic agents]. Huber K Wien Klin Wochenschr; 2000 Sep; 112(17):742-8. PubMed ID: 11042902 [TBL] [Abstract][Full Text] [Related]
39. Combined Abciximab REteplase Stent Study in acute myocardial infarction (CARESS in AMI). Di Mario C; Bolognese L; Maillard L; Dudek D; Gambarati G; Manari A; Guiducci V; Patrizi G; Rusconi LC; Piovaccari G; Hibon AR; Belpomme V; Indolfi C; Olivari Z; Steffenino G; Zmudka K; Airoldi F; Panzarasa R; Flather M; Steg PG Am Heart J; 2004 Sep; 148(3):378-85. PubMed ID: 15389222 [TBL] [Abstract][Full Text] [Related]
40. Facilitated PCI for ST segment elevation myocardial infarction. Young JJ J Invasive Cardiol; 2004 Sep; Suppl():4-9. PubMed ID: 23573663 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]